VERDEYA
LIVE

Serial Number

99148411

Owner

ASPEYA SWITZERLAND SA

Attorney

Tamar Niv Bessinger

Filing Date

Apr 22, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VERDEYA Trademark

Serial Number: 99148411

VERDEYA is a trademark filed by ASPEYA SWITZERLAND SA on April 22, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 32 (Light Beverages), Class 34 (Smokers Articles). The application is currently pending registration.

Owner Contact Info

ASPEYA SWITZERLAND SA (16 trademarks)

AVENUE DE RHODANIE 50
LAUSANNE 1007 , CH

Entity Type: 33

Trademark Details

Filing Date

April 22, 2025

Registration Date

Not Registered

Goods & Services

Medical services; medical services in the field of inhaled therapeutics and pharmaceuticals and in the field of oral administration of pharmaceuticals

Pharmaceutical products, nutraceuticals, vitamins and dietary supplements for topical administration containing hemp-derived cannabinoids with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Pharmaceutical products and nutraceuticals for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep; Pharmaceutical products, preparations, and nutraceuticals for topical administration for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep containing hemp-derived cannabinoids with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Vitamins and dietary supplements; Inhaled pharmaceutical preparations for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep; Pharmaceutical preparations for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep in the form of chewable tablets, medicated gum, medicated lozenges, and powdered nutritional supplement drink mix; nicotine chewing gum for use as an aid to stop smoking; dietetic beverages adapted for medical purposes; tobacco-free cigarettes for smoking cessation purposes

Medical devices for use in treating or diagnosing pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Inhalers for medical purposes, sold empty; dry powder inhalers (DPI) for medical purposes, sold empty; nebulizers for medical purposes; pressurized metered-dose inhalers (pMDI) for medical purposes, sold empty

Non-alcoholic carbonated beverages; Powders for making effervescent isotonic beverages; Energy drinks; Isotonic beverages; Protein-enriched sports beverages; Whey beverages; Syrups for making non-alcoholic fruit juice beverages

Oral vaporizers for smoking purposes; devices for heating tobacco substitutes for the purpose of inhalation; cases for electronic cigarettes, oral vaporizers for smoking purposes, and devices for heating tobacco substitutes for the purpose of inhalation; tobacco substitutes, not for medical purposes; sticks of tobacco substitute for the purpose of being heated for inhalation

Medical research services; scientific research; pharmaceutical drug development services; research and development of medicines, namely, inhaled therapeutics; research and development of new products in the field of pharmaceuticals, namely, products for oral and intra-oral delivery systems

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 15, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 22, 2025 MAFR
NEW APPLICATION ENTERED
Apr 22, 2025 NWAP